TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25094626 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hideaki Tsumuraya und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Stromal Cells, Transforming Growth Factor beta. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
Activated TGFβ signaling in the tumor microenvironment, which occurs independently of epithelial cancer cells, has emerged as a key driver of tumor progression in late-stage colorectal cancer (CRC). This study aimed to elucidate the contribution of TGFβ-activated stroma to serrated carcinogenesis, representing approximately 25% of CRCs and often characterized by oncogenic BRAF mutations. We used a transcriptional signature developed based on TGFβ-responsive, stroma-specific genes to infer TGFβ-dependent stromal activation and conducted in silico analyses in 3 single-cell RNA-seq datasets from a total of 39 CRC samples and 12 bulk transcriptomic datasets consisting of 2014 CRC and 416 precursor samples, of which 33 were serrated lesions. Single-cell analyses validated that the signature was expressed specifically by stromal cells, effectively excluding transcriptional signals derived from epithelial cells. We found that the signature was upregulated during malignant transformation and cancer progression, and it was particularly enriched in CRCs with mutant BRAF compared to wild-type counterparts. Furthermore, across four independent precursor datasets, serrated lesions exhibited significantly higher levels of TGFβ-responsive stromal activation compared to conventional adenomas. This large-scale analysis suggests that TGFβ-dependent stromal activation occurs early in serrated carcinogenesis. Our study provides novel insights into the molecular mechanisms underlying CRC development via the serrated pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
- Department of Multidisciplinary Treatment of Cancer and Regional Medical Support, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.
ORCID-Profile: Hirokazu Okayama, Motonobu Saito, Shotaro Nakajima, Kosaku Mimura
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science KAKENHI
Zitieren
APA
Tsumuraya, H., Okayama, H., Katagata, M., Matsuishi, A., Fukai, S., Ito, M., Sakamoto, W., Saito, M., Momma, T., Nakajima, S., Mimura, K., & Kono, K. (2024). TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094626
Vancouver
Tsumuraya H, Okayama H, Katagata M, Matsuishi A, Fukai S, Ito M, et al. TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094626
BibTeX
@article{Tsumuraya2024,
author = {Tsumuraya, Hideaki and Okayama, Hirokazu and Katagata, Masanori and Matsuishi, Akira and Fukai, Satoshi and Ito, Misato and Sakamoto, Wataru and Saito, Motonobu and Momma, Tomoyuki and Nakajima, Shotaro and Mimura, Kosaku and Kono, Koji},
title = {TGFβ-Responsive Stromal Activation Occurs Early in Serrated Colorectal Carcinogenesis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25094626}
}
EUVIMED